0001144204-14-053582.txt : 20140829 0001144204-14-053582.hdr.sgml : 20140829 20140829210023 ACCESSION NUMBER: 0001144204-14-053582 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140827 FILED AS OF DATE: 20140829 DATE AS OF CHANGE: 20140829 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INTERCEPT PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001270073 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223868459 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 450 W. 15TH STREET STREET 2: SUITE 505 CITY: NEW YORK STATE: NY ZIP: 10011 BUSINESS PHONE: 646-747-1000 MAIL ADDRESS: STREET 1: 450 W. 15TH STREET STREET 2: SUITE 505 CITY: New York STATE: NY ZIP: 10011 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shapiro David CENTRAL INDEX KEY: 0001559570 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35668 FILM NUMBER: 141076262 MAIL ADDRESS: STREET 1: C/O INTERCEPT PHARMACEUTICALS, INC. STREET 2: 18 DESBROSSES ST. CITY: NEW YORK STATE: NY ZIP: 10013 4 1 v388035_4.xml OWNERSHIP DOCUMENT X0306 4 2014-08-27 0 0001270073 INTERCEPT PHARMACEUTICALS INC ICPT 0001559570 Shapiro David C/O INTERCEPT PHARMACEUTICALS, INC. 450 W. 15TH STREET, SUITE 505 NEW YORK NY 10011 0 1 0 0 CMO and EVP - Development Common Stock 2014-08-27 4 M 0 10000 8.6667 A 24253 D Common Stock 2014-08-27 4 S 0 3850 293.0475 D 20403 D Common Stock 2014-08-27 4 S 0 4250 293.8883 D 16153 D Common Stock 2014-08-27 4 S 0 1200 295.6099 D 14953 D Common Stock 2014-08-27 4 S 0 700 296.1364 D 14253 D Options to Purchase Common Stock 8.6667 2014-08-27 4 M 0 10000 0 D 2020-07-20 Common Stock 10000 30131 D All shares underlying this option have vested. This transaction was executed in multiple trades at prices ranging from $292.37 to $293.36. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $293.5 to $294.5. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $295.03 to $296.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $296.115 to $296.185. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. /s/ Bryan Yoon, as attorney-in-fact 2014-08-29